CTSW report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	46 studies	75% ± 23%	Explore
CD8-positive, alpha-beta T cell	36 studies	54% ± 19%	Explore
T cell	23 studies	40% ± 15%	Explore
mature NK T cell	22 studies	73% ± 19%	Explore
gamma-delta T cell	20 studies	64% ± 19%	Explore
CD16-negative, CD56-bright natural killer cell, human	17 studies	85% ± 17%	Explore
CD16-positive, CD56-dim natural killer cell, human	17 studies	83% ± 21%	Explore
mucosal invariant T cell	16 studies	61% ± 20%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	54% ± 19%	Explore
CD4-positive, alpha-beta T cell	13 studies	24% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	12 studies	58% ± 26%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	53% ± 17%	Explore
innate lymphoid cell	9 studies	62% ± 26%	Explore
mast cell	9 studies	23% ± 7%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	70% ± 17%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	7 studies	22% ± 6%	Explore
platelet	6 studies	28% ± 9%	Explore
hematopoietic stem cell	6 studies	37% ± 12%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	26% ± 6%	Explore
central memory CD8-positive, alpha-beta T cell	5 studies	51% ± 18%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	74% ± 9%	Explore
exhausted T cell	5 studies	59% ± 18%	Explore
hematopoietic precursor cell	4 studies	52% ± 19%	Explore
plasmacytoid dendritic cell	4 studies	23% ± 9%	Explore
conventional dendritic cell	4 studies	28% ± 6%	Explore
group 3 innate lymphoid cell	4 studies	71% ± 9%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	41% ± 15%	Explore
plasmablast	3 studies	25% ± 9%	Explore
leukocyte	3 studies	33% ± 16%	Explore
intraepithelial lymphocyte	3 studies	41% ± 12%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	18% ± 1%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	56% ± 21%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	19 studies	29% ± 8%	Explore
lung	5 studies	19% ± 5%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	797.28	576 / 578	83%	16.40	956 / 1155
thymus	92%	201.94	602 / 653	81%	18.80	493 / 605
uterus	84%	107.81	142 / 170	77%	20.27	353 / 459
bladder	81%	212.38	17 / 21	76%	18.91	382 / 504
breast	85%	132.33	392 / 459	63%	10.26	701 / 1118
kidney	69%	112.35	61 / 89	76%	20.13	687 / 901
stomach	84%	139.91	301 / 359	51%	7.60	146 / 286
prostate	82%	131.52	202 / 245	51%	4.48	254 / 502
liver	91%	175.77	205 / 226	40%	5.58	164 / 406
skin	47%	43.41	852 / 1809	71%	21.17	333 / 472
intestine	64%	147.06	623 / 966	50%	6.23	261 / 527
esophagus	64%	64.13	926 / 1445	45%	5.48	82 / 183
ovary	42%	40.64	75 / 180	62%	8.77	268 / 430
spleen	100%	2185.98	241 / 241	0%	0	0 / 0
ureter	0%	0	0 / 0	100%	13.03	1 / 1
lymph node	0%	0	0 / 0	97%	43.39	28 / 29
peripheral blood	94%	6732.37	874 / 929	0%	0	0 / 0
adipose	92%	194.81	1112 / 1204	0%	0	0 / 0
pancreas	19%	14.83	63 / 328	69%	10.11	122 / 178
tonsil	0%	0	0 / 0	87%	26.53	39 / 45
adrenal gland	47%	38.87	121 / 258	30%	3.32	68 / 230
blood vessel	62%	90.27	829 / 1335	0%	0	0 / 0
heart	48%	45.74	417 / 861	0%	0	0 / 0
brain	16%	13.36	431 / 2642	14%	1.11	96 / 705
eye	0%	0	0 / 0	24%	4.11	19 / 80
muscle	13%	8.61	104 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0